Tobira Therapeutics, Inc. Liabilities Assumed
Tobira Therapeutics, Inc. reported Liabilities Assumed of $5.83 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-03.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2016-08-09
- Tobira Therapeutics, Inc. liabilities assumed for the quarter ending 2015-12-31 was $0.00.
- Tobira Therapeutics, Inc. liabilities assumed for the quarter ending 2015-09-30 was $0.00.
- Tobira Therapeutics, Inc. liabilities assumed for fiscal 2015 was $5.83M.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 6 month | Liabilities Assumed 9 month | Liabilities Assumed 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $0.00 derived: sum of 2 quarters · filed 2016-03-03 | $5.83M 10-K · filed 2016-03-03 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $5.83M 10-Q · filed 2015-11-10 | ||
| 2015-06-30 | $5.83M 10-Q · filed 2016-08-09 |